Warning Letter Roundup & Recap – Feb. 7, 2017
Executive Summary
Three device-related warning letters were issued by the agency the week of Feb. 7, including a missive to Taiwan-based glucose monitor firm HMD Biomedical highlighting device design, process control and environmental control lapses.